UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 


  

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported) January 21, 2016

 


  

Net Element, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

001-34887

 

90-1025599

(State or Other Jurisdiction
of Incorporation)
  (Commission File
Number)
 

(IRS Employer
Identification No.)

 

 

 

3363 NE 163rd Street, Suite 705, North Miami Beach, FL     33160

 
             (Address of Principal Executive Offices)                     (Zip Code)  
     
 

(305) 507-8808

 
  (Registrant’s telephone number, including area code)  
     
 

Not Applicable

 
  (Former Name or Former Address, if Changed Since Last Report)  
 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
             

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On January 21, 2016, Net Element, Inc. (the “ Company ”) entered into a Second Additional Letter Agreement (the “ Second Additional Agreement ”) with Kenges Rakishev, an accredited investor (the “ Investor ”). The Second Additional Agreement further modified the terms of the Letter Agreement, dated September 11, 2015, as modified by that certain Additional Letter Agreement dated October 7, 2015, with certain accredited investors listed on the signature pages attached to that Letter Agreement (collectively, the “ Original Agreement ”). Mr. Rakishev is a director of the Company.

 

The Second Additional Agreement provided for the second and final round of $910,000 equity financing to the Company contemplated by the Original Agreement in consideration for the issuance by the Company to the Investor of (i) 4,664,275 restricted shares of the Company’s common stock (the “ Restricted Shares ”) based on $0.1951 per share, equal to the closing trading price of the Company Common Stock reported on The NASDAQ Capital Market on January 20, 2016, the trading date immediately preceding the date when the Investor and the Company committed to the transactions contemplated in the Second Additional Agreement; and (ii) options to purchase 4,664,275 restricted shares of the Company’s common stock on the terms set forth in the Investor’s Form of Option to Purchase Shares of Restricted Common Stock (the “ Restricted Options ”).

 

The Company intends to use the proceeds from the sale of the Restricted Shares and the Restricted Options for general working capital purposes.

 

However, such issuance of Restricted Shares and the Restricted Options is subject to the Company’s stockholders approval within 120 days from the date of Second Additional Agreement (the “ Stockholders Approval ”).

 

Each Restricted Option will expire on the fifth (5 th ) annual anniversary of the date of the Second Additional Agreement and shall be exercisable (prior to its expiration) into one (1) Restricted Share at the exercise price equal to $0.2146 (which is 110% of the closing trading price of the Company Common Stock reported on The NASDAQ Capital Market on January 20, 2016, the trading date immediately preceding the date when the Investor and the Company committed to the transactions contemplated in the Second Additional Agreement). The Investor may elect to exercise his Restricted Options through a cashless exercise, in which case the Investor would receive upon such exercise the “net number” of shares of Company common stock determined according to the formula set forth in the Restricted Option.

 

In the event that the Stockholders Approval is not obtained within 120 days from the date Second Additional Agreement, the Investor and the Company agreed that at the Investor’s election, (i) the purchase price for the Restricted Shares and the Restricted Options shall be automatically amended to be equal to the product of (x) 4,664,275 and (y) the sum of $0.1951 and $0.125, in which case the Investor will have paid to the Company the difference between such price and the previously paid purchase price for the Restricted Shares and the Restricted Options, (ii) the number of Restricted Shares and the Restricted Options issuable to the Investor will be adjusted to be equal to the quotient determined by dividing (I) $910,000 by (II) $0.3201, or (iii) the Restricted Options will not be issued and the Investor will be issued the number of Restricted Shares calculated on the basis of $0.1951 per share purchase price.

 

The Restricted Shares and the Restricted Options, including the shares of common stock issuable, subject to compliance with Rule 144 under the Securities Act of 1933, as amended (the " 1933 Act ")), upon exercise of the Restricted Options, were issued to the Investor in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the 1933 Act. All of the Restricted Shares and Restricted Options (including the shares of common stock issuable, subject to compliance with Rule 144 under the 1933 Act, upon exercise of the Restricted Options) will be restricted securities within the meaning of Rule 144 under the 1933 Act and, accordingly, each of the stock certificates of the Company to be issued evidencing such securities will contain a standard Rule 144 restrictive securities legend.

 

2  

 

 

The Second Additional Agreement provides that under no circumstances may the aggregate number shares of Company common stock issued to the Investor under the Agreement at any time exceed 19.99% of the total number of shares of Company common stock issued and outstanding or of the voting power unless the Company has obtained either (i) its stockholders' approval of the issuance of more than such number of shares of Common Stock pursuant to NASDAQ Marketplace Rule 5635 or (ii) a waiver from The NASDAQ Stock Market of the Company’s compliance with Rule 5635.

 

The foregoing is only a brief description of the terms of the Second Additional Agreement, the Restricted Shares and the Restricted Options, does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety by reference to the Second Additional Agreement and the Form of Option to Kenges Rakishev to Purchase Shares of Restricted Common Stock which are filed as Exhibits 10.1 and 4.1, respectively, to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 3.02 Unregistered Sales of Equity Securities

 

The disclosures in Item 1.01 of this Current Report are incorporated herein by reference.

 

Item 3.03 Material Modification to Rights of Security Holders

 

The information set forth in Item 1.01 of this Current Report is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

  Exhibit No. Description
     
  4.1 Form of Option to Kenges Rakishev to Purchase Shares of Restricted Common Stock
     
  10.1 Second Additional Letter Agreement, dated as of January 21, 2016, between the Company and Kenges Rakishev
     

 

3  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 21, 2016

 

  NET ELEMENT, INC.  
       
  By: /s/  Jonathan New  
  Name:   Jonathan New  
  Title:    

Chief Financial Officer 

 

 

 

4  

 

 

EXHIBIT INDEX

 

 

Exhibit No.   Description
     
4.1   Form of Option to Kenges Rakishev to Purchase Shares of Restricted Common Stock
     
10.1   Second Additional Letter Agreement, dated as of January 21, 2016, between the Company and Kenges Rakishev
     

 

 

5  

Exhibit 4.1

 

EXHIBIT A

 

FORM OF OPTION

 

THIS OPTION AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 UNDER THE ACT.

 

NET ELEMENT, INC.

 

OPTION TO PURCHASE SHARES OF RESTRICTED COMMON STOCK

 

__________, 2016

V oid After __________, 2021

 

This Certifies That, for value received, Kenges Rakishev (the “ Investor ”), with its principal office located across from such party’s name on the first page of the Purchase Agreement (as defined below) or its assigns (the “ Holder ”), is entitled to subscribe for and purchase from Net Element, Inc. , a Delaware corporation (the “ Company ”), with its principal office at 3363 NE 163 Street, Suite 705, North Miami Beach, FL 33160, those Exercise Shares (as defined below) at the Exercise Price (as defined below).

 

This option to purchase shares of restricted common stock of the Company is issued as part of a series of similar options (collectively, the “ Options ”) issued pursuant to the terms of that certain Letter Agreement, dated as of September 11, 2015, by and among the Company, the Investor and certain other parties thereto, as modified by that certain Additional Letter Agreement dated as of October 7, 2015 and that certain Second Additional Letter Agreement dated as of January 8, 2016 (as so modified, the “ Purchase Agreement ”). Pursuant to the Purchase Agreement, the Company is selling to Investor certain restricted shares of the Company’s common stock and this option to purchase shares of restricted common stock of the Company (this “ Option ”).

 

1. Definitions. As used herein, the following terms shall have the following respective meanings:

 

(a) Exercise Period ” shall mean the period commencing on the date hereof and ending on __________, 2021 .

 

(b) Exercise Price ” shall mean [ 110% of the closing trading price per one (1) share of the Company’s common stock (“ Common Stock ”) reported on The NASDAQ Capital Market on _____________, s ubject to adjustment pursuant to Section 5 below.]

 

(c) Exercise Shares ” shall mean _____________ shares of the Common Stock (which shall be equal to the number of shares set forth opposite Investor’s name on Exhibit A to the Purchase Agreement under the column “Number of Restricted Options”).

 

2. Exercise of Option. The rights represented by this Option may be exercised in whole or in part at any time during the Exercise Period, by delivery of the following to the Company at its address set forth above (or at such other address as it may designate by notice in writing to the Holder):

 

(a) An executed Notice of Exercise in the form attached hereto;

 

1

 

 

(b) Payment of the Exercise Price either (i) in cash or by check, or (ii) by cancellation of indebtedness; and

 

(c) This Option.

 

Upon the exercise of the rights represented by this Option, a certificate or certificates for the Exercise Shares so purchased, registered in the name of the Holder or persons affiliated with the Holder, if the Holder so designates, shall be issued and delivered to the Holder within a reasonable time after the rights represented by this Option shall have been so exercised. In the event that this Option is being exercised for less than all of the then-current number of Exercise Shares purchasable hereunder, the Company shall, concurrently with the issuance by the Company of the number of Exercise Shares for which this Option is then being exercised, issue a new Option of like tenor exercisable for the remaining number of Exercise Shares purchasable hereunder.

 

The person in whose name any certificate or certificates for Exercise Shares are to be issued upon exercise of this Option shall be deemed to have become the holder of record of such shares on the date on which this Option was surrendered and payment of the Exercise Price was made, irrespective of the date of delivery of such certificate or certificates, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are open.

 

2.1 Net Exercise . Notwithstanding any provisions herein to the contrary, if the fair market value of one Exercise Share is greater than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Option by payment of cash, the Holder may elect to receive shares equal to the value (as determined below) of this Option (or the portion thereof being canceled) by surrender of this Option at the principal office of the Company together with the properly endorsed Notice of Exercise in which event the Company shall issue to the Holder a number of Exercise Shares computed using the following formula:

 

X = Y * (A-B)

A

  

Where X = the number of Exercise Shares to be issued to the Holder
     
  Y = the number of Exercise Shares purchasable under this Option or, if only a portion of this Option is being exercised, the portion of this Option being canceled (at the date of such calculation)
     
  A = the fair market value of one Exercise Share (at the date of such calculation)
     
  B = Exercise Price (as adjusted to the date of such calculation)

  

3. Covenants of the Company.

 

3.1 Covenants as to Exercise Shares. The Company covenants and agrees that all Exercise Shares that may be issued upon the exercise of the rights represented by this Option will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The Company further covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved, free from preemptive rights, a sufficient number of Exercise Shares to provide for the exercise of the rights represented by this Option. If at any time during the Exercise Period the number of authorized but unissued Exercise Shares shall not be sufficient to permit exercise of this Option, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued Exercise Shares to such number of shares as shall be sufficient for such purposes.

 

2

 

 

4. Representations of Holder.

 

4.1 Acquisition of Option for Personal Account. The Holder represents and warrants that Holder is acquiring this Option and the Exercise Shares solely for Holder’s account for investment and not with a view to or for sale or distribution of said Option or Exercise Shares or any part thereof. The Holder also represents that the entire legal and beneficial interests of this Option and Exercise Shares the Holder is acquiring is being acquired for, and will be held for, Holder’s account only.

 

4.2 Securities Are Not Registered.

 

(a) The Holder understands that this Option and the Exercise Shares have not been registered under the Act on the basis of an applicable exemption from such registration. The Holder realizes that the basis for the exemption may not be present if, notwithstanding Holder’s representations, the Holder has a present intention of acquiring the securities for a fixed or determinable period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing the securities. The Holder has no such present intention.

 

(b) The Holder recognizes that this Option and the Exercise Shares must be held indefinitely unless they are subsequently registered under the Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to register this Option or the Exercise Shares of the Company, or to comply with any exemption from such registration.

 

(c) The Holder is aware that neither this Option nor the Exercise Shares may be sold pursuant to Rule 144 adopted under the Act unless certain conditions are met, including, among other things, the existence of a public market for the shares, the availability of certain current public information about the Company, the resale following the requirements of Rule 144.

 

4.3 Economic Risk and Protection of Interest.

 

(a) The Holder has substantial experience in evaluating and investing in private placement transactions of securities in companies similar to the Company so that Holder is capable of evaluating the merits and risks of Holder’s investment in the Company and has the capacity to protect Holder’s own interests.

 

(b) The Holder represents that by reason of Holder’s, or of Holder’s management’s, business or financial experience, the Holder has the capacity to protect Holder’s own interests in connection with the transactions contemplated herein. Further, the Holder is aware of no publication of any advertisement in connection with the transactions contemplated herein.

 

4.4 Accredited Investor. The Holder represents that Holder is an “ accredited investor ” within the meaning of Regulation D under the Act.

 

4.5 Corporate Information. The Holder has had the full and complete opportunity to discuss the Company’s business, management and financial affairs with directors, officers and management of the Company and has had the full and complete opportunity to review the Company’s operations and facilities. The Holder has also had the opportunity to ask questions of and receive answers from, the Company and its management regarding the terms and conditions herein.

 

4.6 Residence. If the Holder is an individual, then the Holder resides in the state or province identified in the address of the Holder set forth below; if the Holder is a partnership, corporation, limited liability Company or other entity, then the office or offices of the Holder in which Holder’s investment decision was made is located at the address or addresses of the Holder set forth herein.

 

3

 

 

4.7 Disposition of Option and Exercise Shares.

 

(a) The Holder further agrees not to make any disposition of all or any part of this Option or Exercise Shares in any event unless and until:

 

(i) The Company shall have received a letter secured by the Holder from the Securities and Exchange Commission stating that no action will be recommended to the Commission with respect to the proposed disposition;

 

(ii) There is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance with said registration statement; or

 

(iii) The Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if requested by the Company or its transfer agent, the Holder shall have furnished the Company and/or its transfer agent with an opinion of counsel for the Holder to the effect that such disposition will not require registration of such Option or Exercise Shares under the Act or any applicable state securities laws.

 

(b) The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder may bear the following legend:

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR (B) AN OPINION OF COUNSEL, IN A REASONABLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS, OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

 

5. Adjustment of Exercise Price and Number of Exercise Shares. In the event of changes in the series of equity securities of the Company comprising the Exercise Shares by reason of stock dividends, splits, recapitalizations, reclassifications, combinations, conversions or exchanges of shares, separations, reorganizations, liquidations, or the like, the number and class of Exercise Shares available under this Option in the aggregate and the Exercise Price shall be correspondingly adjusted to give the Holder of this Option, on exercise for the same aggregate Exercise Price, the total number, class, and kind of shares as the Holder would have owned had this Option been exercised prior to the event and had the Holder continued to hold such shares until after the event requiring adjustment. The form of this Option need not be changed because of any adjustment in the number of Exercise Shares subject to this Option.

 

6. Fractional Shares. No fractional shares shall be issued upon the exercise of this Option as a consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) issuable upon exercise of this Option may be aggregated for purposes of determining whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the product resulting from multiplying the then current fair market value of an Exercise Share by such fraction.

 

4

 

 

7. Transfer of Option and Exercise Shares. Subject to applicable laws and the restriction on transfer set forth on the first page of this Option, this Option and all rights hereunder are transferable, by the Holder in person or by its duly authorized attorney, upon delivery of this Option and the form of assignment attached hereto to any transferee designated by Holder. The transferee shall sign an investment letter in form and substance satisfactory to the Company.

 

8. No Stockholder Rights. This Option in and of itself shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company.

 

9. Lost, Stolen, Mutilated or Destroyed Option. If this Option is lost, stolen, mutilated or destroyed, the Company may, on such terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Option, include the surrender thereof), issue a new Option of like denomination and tenor as the Option so lost, stolen, mutilated or destroyed. Any such new Option shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Option shall be at any time enforceable by anyone.

 

10. Notices, etc. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed facsimile or electronic mail if sent during normal business hours of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address listed on the signature page and to Holder at Holder’s address listed in the first paragraph hereto, or at such other address as the Company or Holder may designate by ten (10) days advance written notice to the other parties hereto.

 

11. Acceptance. Receipt of this Option by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.

 

12. Governing Law. This Option and all rights, obligations and liabilities hereunder shall be governed by and construed under the laws of the State of Delaware in all respects as such laws are applied to agreements among Delaware residents entered into and performed entirely within Delaware. THE COMPANY AND THE HOLDER HEREBY WAIVE THEIR RIGHT TO A TRIAL BY JURY WITH RESPECT TO DISPUTES ARISING UNDER THIS OPTION AND CONSENT TO A BENCH TRIAL WITH THE APPROPRIATE JUDGE ACTING AS THE FINDER OF FACT.

 

[SIGNATURE PAGE FOLLOWS]

 

5

 

 

In Witness Whereof , the Company has caused this Option to Purchase Common Stock to be executed by its duly authorized officer as of the date first set forth above.

 

 

  Net Element, Inc.  
     
     
  By:    
  Name:    
  Title:    
       

  

 

 

 

 

 

6

 

NOTICE OF EXERCISE

 

TO: Net Element, Inc.

 

(1) ¨ The undersigned hereby elects to purchase ________ shares of the Common Stock of Net Element, Inc. (the “ Company ”) pursuant to the terms of the attached Option, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

¨ The undersigned hereby elects to purchase ________ shares of the Common Stock of Net Element, Inc. (the “ Company ”) pursuant to the terms of the net exercise provisions set forth in Section 2.1 of the attached Option, and shall tender payment of all applicable transfer taxes, if any.

 

(2) Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name as is specified below:

 

________________________

(Name)

 

________________________

________________________

(Address)

 

(3) The undersigned represents that (i) the aforesaid shares of Common Stock are being acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares; (ii) the undersigned is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision regarding its investment in the Company; (iii) the undersigned is experienced in making investments of this type and has such knowledge and background in financial and business matters that the undersigned is capable of evaluating the merits and risks of this investment and protecting the undersigned’s own interests; (iv) the undersigned understands that the shares of Common Stock issuable upon exercise of the Option have not been registered under the Securities Act of 1933, as amended (the “ Securities Act ”), by reason of a specific exemption from the registration provisions of the Securities Act, which exemption depends upon, among other things, the bona fide nature of the investment intent as expressed herein, and, because such securities have not been registered under the Securities Act, they must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available; (v) the undersigned is aware that the aforesaid shares of Common Stock may not be sold pursuant to Rule 144 adopted under the Securities Act unless certain conditions set forth in Rule 144 are met; (vi) the undersigned is an “accredited investor” within the meaning of Regulation D under the Securities Act; and (vii) the undersigned agrees not to make any disposition of all or any part of the aforesaid shares of Common Stock unless and until there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said registration statement, or the undersigned has provided the Company and its transfer agent with an opinion of counsel stating that such registration is not required.

 

     
(Date)   (Signature)  
       
       
    (Print name)  

 

 

 

 

7

 

 

ASSIGNMENT FORM

 

(To assign the foregoing Option, execute this form and supply required information. Do not use this form to purchase shares.)

 

For Value Received , the foregoing Option and all rights evidenced thereby are hereby assigned to

 

 

Name:    
  (Please Print)
   
Address:    
  (Please Print)

 

Dated:  __________, 20__  
     
Holder’s    
Signature:      
     
Holder’s    
Address:      

  

NOTE : The signature to this Assignment Form must correspond with the name as it appears on the face of the Option, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Option.

 

 

 

8

 

 

 

Exhibit 10.1

 

 

Second additional LetTER Agreement

 

VIA EMAIL

 

Kenges Rakishev

c/o SAT & Company 
241 Mukanova Street 
Almaty Kazakhstan 050008

 

Re: Letter Agreement, dated as of September 11, 2015, Regarding Equity Investment for Funding of Net Element, as modified by that certain Additional Letter Agreement dated October 7, 2015 (collectively, the “ Original Letter Agreement ”)

 

 

This second additional letter agreement is dated as of January 21, 2016 (the “ Additional Funding Effective Date ”). The undersigned intend that (a) the terms of this second additional letter agreement will modify and supplement the terms and provisions of the Original Letter Agreement. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Original Letter Agreement.

 

Whereas, in the initial funding pursuant to the Original Letter Agreement, the aggregate amount of $1,590,000 was funded and, upon the approval of the issuance of the Restricted Shares and the Restricted Options by the Company’s shareholders’, 11,357,143 of the Restricted Shares and 11,357,143 of the Restricted Options were issued to the accredited investors that funded such $1,590,000 to the Company pursuant to the Original Letter Agreement.

 

Whereas, the Original Letter Agreement contemplated the funding to Net Element, Inc., a Delaware corporation (the “ Company ”), of up to $2,500,000 by the accredited investors in consideration for the issuance to such funding investors of restricted shares of common stock of the Company (“ Common Stock ”) and options to purchase restricted shares of Common Stock.

 

Whereas, the Special Committee consisting of three (3) independent and disinterested directors established and appointed by the Board of Directors of the Company previously authorized the funding the Company of up to $2,500,000 in the aggregate and the issuance to such funding investors of the appropriate number of restricted shares of Common Stock and options to purchase restricted shares of Common Stock as consideration for such aggregate funding under the Original Letter Agreement.

 

Whereas, $910,000 remains unfunded under the Original Letter Agreement.

 

Whereas, Kenges Rakishev desires to fund such remaining $910,000 to the Company in order to meet the Company’s current working capital requirements.

 

Now, Therefore, the parties hereby agree as follows:

 

1. On the Additional Funding Effective Date, Kenges Rakishev shall fund such remaining $910,000 to the Company. In consideration for such funding, the Company agrees to issue to Kenges Rakishev, upon and subject to obtaining the Company’s shareholders approval for such issuance for purposes of the Nasdaq Listing Rules (the “ Stockholders Approval ”) within 120 days from the date hereof:

 

(i) such number of restricted (i.e., issued in reliance on an applicable exemption from registration under the Securities Act, and any disposition of such shares to be subject to Rule 144 of the Securities Act) shares of common stock of the Company (“ Common Stock ”) as shall equal $910,000 divided by $0.1951 (the closing consolidated bid price per one (1) share of Common Stock reported on The NASDAQ Capital Market on the trading date immediately preceding the Additional Funding Effective Date (the Additional Funding Effective Date being the date when the Company entered into a binding agreement to issue the securities)) (collectively, the “ Consideration Shares ”); and

 

 

 

 

 

(ii) such number of options to purchase restricted shares of Common Stock as will equal the number of the Consideration Shares (each, an “ Option ”). Each Option shall expire on the fifth (5 th ) annual anniversary of such Option’s issuance date and shall be exercisable (prior to its expiration) into one (1) restricted share of Common Stock at the exercise price equal to $0.2146 (which is 110% of the closing consolidated bid price per one (1) share of Common Stock reported on The NASDAQ Capital Market on the date immediately preceding the Additional Funding Effective Date). The form of option agreement with respect to the Options is attached hereto as Exhibit A .

 

2. In the event that the Stockholders Approval is not obtained within 120 days from the date hereof, then at Kenges Rakishev’s election, either (i) the purchase price for the Consideration Shares and the Options shall be hereby automatically amended to be equal to the product of (x) the number of Consideration Shares calculated pursuant to paragraph (1)(i) above and (y) the sum of (A) $0.1951 and (B) $0.125, in which case Kenges Rakishev shall have paid to the Company the difference between the previously paid purchase price for the Consideration Shares and Options and the purchase price for the Consideration Shares and Options calculated as set forth in this clause (i) of this paragraph 2, (ii) the number of Consideration Shares and Options issuable to Kenges Rakishev shall be adjusted to be equal to, in each case, the quotient determined by dividing (I) $910,000 by (II) $0.3201, or (iii) the Options shall not be issued and Kenges Rakishev shall be issued the number of Consideration Shares calculated in accordance with paragraph (1)(i) above.

 

3. Notwithstanding anything to the contrary contained in this second additional letter agreement or any other documents, at no time shall the Company issue shares of Common Stock if such transaction would result in the issuance of more than 19.9% of the amount of issued and outstanding Common Stock unless (i) the Company’s shareholders shall have approved the issuance of shares of common stock in excess of 20%, or (ii) the Nasdaq has provided a waiver of Listing Rule 5635.

 

4. This second additional letter agreement constitutes the entire agreement among the parties hereto pertaining to the subject matter hereof and supersedes all prior agreements and understandings pertaining thereto. This second additional letter agreement may not be amended or modified in any respect, except by the written agreement of the parties hereto. No party hereto may, without the prior written consent of the other party hereto, assign or otherwise transfer, in whole or in part, any of its rights and obligations under this second additional letter agreement. Except as expressly provided for herein, nothing in this second additional letter agreement shall confer any rights upon any person that is not a party hereto or the successor or permitted assignee of a party to this second additional letter agreement. This second additional letter agreement shall be governed by, and shall be construed, interpreted and enforced in accordance with the laws of the State of Florida without regard to its choice of law provisions that would require the application of the law of another jurisdiction. This second additional letter agreement may be executed and delivered (including by facsimile or electronic mail transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed and delivered shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Copies of executed counterparts transmitted by telecopy or other electronic transmission service shall be considered original executed counterparts.

 

 

 

 

[Signatures are on next page.]

 

 

2  

 

 

 

 

Please indicate your consent to the terms of this second additional letter agreement by signing and dating this second letter agreement and returning it to the undersigned.

 

 

  NET ELEMENT, INC.  
       
  By: /s/ Oleg Firer  
  Name: Oleg Firer  
  Title: Chief Executive Officer  

 

AGREED AND ACCEPTED BY:  
   
   
/s/  Kenges Rakishev  
KENGES RAKISHEV  
   

 

 

 

3  

 

 

 

Exhibit A

 

Form of Option

 

[Attached hereto]

 

 

 

 

 

 

 

 

 

 

 

 

4